
Cancer vaccine uses COVID immune memory
October 7, 2026




Celloram develops cancer vaccine using COVID immune memory to activate T cells against tumors in mice.
Apixaban may cut stroke risk in kidney patients with atrial fibrillation and chronic kidney disease.